Share
As OpenAI continues to prepare for a potential IPO, the company has brought in Dali Rajic from cybersecurity firm Wiz to lead its revenue operations, signaling a strategic shift in leadership.
OpenAI's executive reshuffle is gaining momentum with the appointment of Dali Rajic as the new Chief Revenue Officer (CRO). Rajic, previously the President and COO at cybersecurity firm Wiz, succeeds Denise Dresser, who held the position for just nine months. This move underscores OpenAI’s commitment to strengthening its revenue generation capabilities as it eyes a potential initial public offering (IPO).
The hiring of Rajic comes at a critical juncture for OpenAI. The company has been under pressure to commercialize its groundbreaking AI technologies and build a robust revenue model. With the AI market projected to reach $190.6 billion by 2025, according to MarketsandMarkets, the stakes are high for OpenAI to capture a significant share.
Rajic’s background in scaling business operations and driving revenue growth at Wiz makes him a strategic fit for OpenAI. At Wiz, he played a crucial role in expanding the company's customer base and optimizing operational efficiency. His experience in cybersecurity, a sector that heavily relies on advanced AI technologies, aligns well with OpenAI’s focus on developing secure and reliable AI solutions.
The decision to replace Dresser after such a short tenure highlights the urgency within OpenAI to find the right leadership for its revenue operations. While Dresser brought valuable insights from her previous roles at tech giants like Google and Microsoft, the rapid evolution of the AI landscape may have necessitated a more specialized skill set.
For investors, this executive change signals a potential acceleration in OpenAI’s path to profitability and market leadership. The company has already secured significant funding, with its latest Series F round raising $2 billion at a valuation of over $29 billion. However, the transition to a sustainable revenue model remains a key challenge.
Rajic's appointment could also influence OpenAI’s approach to partnerships and product development. His expertise in scaling operations may lead to more strategic collaborations and a broader portfolio of commercialized AI products. This could be particularly important as OpenAI competes with other tech giants like Google, Microsoft, and Meta, which are also heavily investing in AI.
The market's reaction to this news will be crucial. Analysts will be watching closely for any signs of improved financial performance and strategic direction from OpenAI. A successful transition under Rajic’s leadership could bolster investor confidence and pave the way for a smoother IPO process.
The hiring of Dali Rajic as CRO represents a significant step in OpenAI’s ongoing efforts to solidify its market position and prepare for future growth. As the company continues to navigate the dynamic AI landscape, investors will be keenly observing how this leadership change translates into tangible business outcomes.
Tags
Original Sources
OpenAI hires new CRO as executive shake-up continues | TechCrunch
↗ https://techcrunch.com/2026/08/13/openai-hires-new-cro-as-executive-shake-up-continues
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
17 August 2026
113 articles
Related Articles

FDA Panel Endorses Replimune’s Melanoma Drug; Novo Nordisk Faces Setback
Finance & Markets · 3 min

Grove AI Transforms Clinical Trial Recruitment with Voice Technology
Finance & Markets · 3 min

Throne Science Raises $10M to Transform Gut Health Monitoring with AI-Powered Smart Toilets
Finance & Markets · 4 min
Related Articles

FDA Panel Endorses Replimune’s Melanoma Drug; Novo Nordisk Faces Setback
Finance & Markets · 3 min

Grove AI Transforms Clinical Trial Recruitment with Voice Technology
Finance & Markets · 3 min

Throne Science Raises $10M to Transform Gut Health Monitoring with AI-Powered Smart Toilets
Finance & Markets · 4 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.